Actinium: Q4 Earnings Snapshot

By The Associated Press
March 30, 2026 | 6:28 PM

NEW YORK (AP) — NEW YORK (AP) — Actinium Pharmaceuticals Inc. (ATNM) on Monday reported a loss of $5.9 million in its fourth quarter.

On a per-share basis, the New York-based company said it had a loss of 19 cents.

For the year, the company reported that its loss narrowed to $33.9 million, or $1.09 per share. Revenue was reported as $90,000.

In the final minutes of trading on Monday, the company’s shares hit 99 cents. A year ago, they were trading at $1.81.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATNM at https://www.zacks.com/ap/ATNM

A whiplash election year enters its final stretch as Trump holds wild cards

By The Associated Press
September 6, 2026 | 7:30 AM

WASHINGTON (AP) — In the earliest days of this election cycle, the U.S. wasn't at war with Iran. The East Wing of the White House was still standing and the Kennedy Center wasn't threatened with demolition. Artificial intelligence data centers weren't bipartisan shorthand for the tech sector's excess. Democratic socialists were largely confined to the outer edges of political discourse. Lake Ontario's name wasn’t in question. Since President Donald Trump entered politics more than a decade ago, he's had a knack for dominating the national conversation so thoroughly that it can be hard to keep up. But as the final midterm of his presidency rapidly approaches, the landscape is proving especially volatile, with Trump often stirring the tumult. “Some of these things are out of our control,” House Speaker Mike Johnson, a Louisiana Republican, told reporters last week when pressed on whether the frenzy will hurt his party's election prospects.

Related Stories